Correlation Between Chemours and Vitro SAB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chemours and Vitro SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chemours and Vitro SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Chemours and Vitro SAB de, you can compare the effects of market volatilities on Chemours and Vitro SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chemours with a short position of Vitro SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chemours and Vitro SAB.

Diversification Opportunities for Chemours and Vitro SAB

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Chemours and Vitro is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding The Chemours and Vitro SAB de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vitro SAB de and Chemours is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Chemours are associated (or correlated) with Vitro SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vitro SAB de has no effect on the direction of Chemours i.e., Chemours and Vitro SAB go up and down completely randomly.

Pair Corralation between Chemours and Vitro SAB

Assuming the 90 days horizon The Chemours is expected to generate 1.32 times more return on investment than Vitro SAB. However, Chemours is 1.32 times more volatile than Vitro SAB de. It trades about 0.01 of its potential returns per unit of risk. Vitro SAB de is currently generating about -0.16 per unit of risk. If you would invest  39,702  in The Chemours on September 3, 2024 and sell it today you would lose (1,195) from holding The Chemours or give up 3.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy93.09%
ValuesDaily Returns

The Chemours  vs.  Vitro SAB de

 Performance 
       Timeline  
Chemours 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in The Chemours are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Chemours may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Vitro SAB de 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitro SAB de has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Vitro SAB is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Chemours and Vitro SAB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chemours and Vitro SAB

The main advantage of trading using opposite Chemours and Vitro SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chemours position performs unexpectedly, Vitro SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitro SAB will offset losses from the drop in Vitro SAB's long position.
The idea behind The Chemours and Vitro SAB de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account